This site is operated by iGen Capital LTD. iGen Capital LTD is a company registered in England and Wales with company number 09986777. Its registered office is at Second Floor, 123 Aldersgate Street, London, EC1A 4JQ, United Kingdom and is an Appointed Representative of Finex LLP, which is authorised and regulated in the UK by the Financial Conduct Authority (“FCA”) with firm reference number 507537 and in the US by the National Futures Association (“NFA”) with firm ID number 0461979.
iGen Capital LTD is compensated by the hedge fund manager or company it represents. The manager has a standard fee schedule and is not adding a differential to compensate iGen Capital LTD, which means there is no additional cost to the investor in utilizing iGen Capital LTD services. iGen Capital LTD is not affiliated with and has no relationship with the hedge fund managers or companies it represents other than a separate written agreement covering their marketing and consulting services for the benefit of the hedge fund manager or company owner(s).
This site is not intended for any person in any jurisdiction where iGen Capital LTD would become subject to license or registration regulations of that jurisdiction, or the publication or availability of the contents is prohibited.
Description of this Site:
This site is for informational purposes only. It is not intended as and should not be construed as financial, investment, tax, legal, regulatory, or other advice.
None of the contents of this site is an offer to sell or the solicitation of any offer to buy securities in any investment vehicle or account sponsored, managed and/or advised by iGen Capital LTD (each a “Product”). It is not an offer or sale of securities in the United States or to, or for the account or benefit of, any US person (as defined in relevant US securities laws, including residents of the United States or partnerships or corporations organised there). Unless specifically stated, no fund referred to on this site has been registered under the US Investment Company Act of 1940 and no interests therein are registered under the US Securities Act of 1933.
The contents of this site are the intellectual property of iGen Capital LTD and its third-party licensors and may not be copied, distributed, uploaded, posted, republished, decompiled, disassembled, reverse-engineered or transmitted in any way without the prior written consent of iGen Capital LTD. The intellectual property rights in the iGen Capital LTD name and logo are owned by iGen Capital LTD. Nothing in these terms or on this site should be construed as granting any licence or right to use the iGen Capital LTD name or logo or any other contents of this site. iGen Capital LTD enforces and will enforce any infringements of its intellectual property rights to the fullest extent permitted by the law.
None of iGen Capital LTD, its directors or employees makes any representations or warranties regarding this site or its contents (including but not limited to, with respect to accuracy, adequacy, reliability, timeliness, completeness or suitability) and all contents are provided “as is”. iGen Capital LTD, to the fullest extent permitted by law, expressly disclaims all representations and warranties, express or implied, as to this site and its contents, including any implied warranties of merchantability, fitness for a particular purpose, title, non-infringement and availability. iGen Capital LTD also disclaims liability for errors and omissions in this site and its contents.
Liability and Indemnity:
In no event shall iGen Capital LTD , its directors or employees be liable for any claims, liabilities, losses, costs or damages of any kind, including (i) direct, indirect, consequential, punitive, exemplary, incidental or special losses or (ii) loss of profit, loss of business, business interruption, loss of business opportunity or loss of data arising out of or in any way connected with (a) your use of or inability to access and/or use this site, (b) the contents of this site, or (c) the contents of any third party sites linked or linking to this site. The foregoing applies even if iGen Capital LTD, its directors or employees have been advised of the possibility of such claims, liabilities, losses, costs or damages or could have foreseen them.
iGen Capital LTD, its directors and employees shall not be responsible for any failure by you or any third party to comply with these terms or with applicable law. If any part of this term is unenforceable under applicable law, the aggregate liability of iGen Capital LTD, its directors and employees will be limited to the maximum extent permitted by such law and shall in no event exceed £100.
Your sole remedy for dissatisfaction with your use of this site is to cease using this site.
You agree, at your own expense, to indemnify, defend and hold iGen Capital LTD , its directors, members and employees harmless from and against any claims, liabilities, losses, costs or damages of any kind (including any legal fees and costs) suffered or incurred by these parties in connection with any claim arising out of any breach of these terms by you. You shall cooperate as fully as reasonably required or requested in the defence of any such claim. iGen Capital LTD may, at its own expense, assume the exclusive defence and control of any matter otherwise subject to indemnification by you and you shall not in any event settle any matter without the written consent of iGen Capital LTD.
Third Party Sites:
iGen Capital LTD is not responsible for the contents of any third-party sites linked or linking to this site and disclaims all liability arising from your use of or reliance on such sites, their contents and any products and services referred to on such sites. Your use of any such sites is at your own risk. iGen Capital LTD ’s inclusion of links to third party sites does not imply any endorsement of any kind by iGen Capital LTD of such third parties, their sites or their products or services.
You must not use any data mining, robots or similar data gathering or extraction programs or methods, whether automated or manual, to access, acquire, copy or monitor any portion of this site or any of its contents.
You must not misuse this site by knowingly introducing viruses, trojans, worms, logic bombs or other material that is malicious or technologically harmful. You must not attempt to gain unauthorised access to this site, the server on which it is stored or any server, computer or database connected to this site. You must not attack this site via a denial-of-service attack or a distributed denial-of service attack. By breaching this provision, you would commit a criminal offence under the Computer Misuse Act 1990 (UK). iGen Capital LTD will report any such breach to the relevant law enforcement authorities and will co-operate with those authorities by disclosing your identity to them. In the event of such a breach, your right to use this site will cease immediately.
This site and its contents may contain forward-looking statements that are based on current indicators, expectations and assumptions that iGen Capital LTD believes to be reasonable but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results will not differ from those expressed or implied by such forward-looking statements. These statements speak only as of the date on which they are made.
A failure by iGen Capital LTD to enforce a provision of these terms or act on a breach or default by you does not constitute a waiver of any of iGen Capital LTD ’s rights or remedies.
These terms constitute the entire agreement between iGen Capital LTD and you with respect of your use of this site and they supersede all prior or contemporaneous communications, agreements and understandings between iGen Capital LTD and you with respect to the subject matter hereof.
These terms are governed by and shall be construed in accordance with the laws of England and Wales. You agree that the Courts of England shall have exclusive jurisdiction over any disputes arising in relation to use and browsing of this site.
Please send any questions about these terms or the contents of this site to: email@example.com
We are committed to ensuring that your privacy is protected. When we ask you to provide certain information by which you can be identified when using this website, then you can be assured that it will only be used in accordance with this policy statement.
We may change this policy from time to time by updating this page. You should check this page from time to time to ensure that you are happy with any changes. This policy is effective from June 2013.
If you have any requests concerning your personal information or any queries with regard to these practices please contact iGen Capital at Second Floor, 123 Aldersgate Street, London, EC1A 4JQ, United Kingdom.
iGen Capital Limited collects personal information from visitors to the website through the use of online forms and every time you email us your details.
Use of personal information:
iGen Capital Limited processes personal information collected via the website for the purposes of:
If you have provided your personal details to us and you wish to change your preferences please inform us at the address provided below if you do not wish to receive information about:
Alternatively, you may opt-out of receiving additional information from iGen Capital Limited or related 3rd parties at any time by sending us an email to firstname.lastname@example.org or by writing to us at the following address: iGen Capital, Second Floor, 123 Aldersgate Street, London, EC1A 4JQ, United Kingdom.
iGen Capital Limited may also use and disclose information in aggregate (so that no individuals are identified) for marketing and strategic development purposes.
iGen Capital Limited will only disclose personal information to other companies within its group of companies, business partners, government bodies and law enforcement agencies, successors in title to its business and suppliers engaged to process information on its behalf. Your details will never be sent to any third party.
Given that the Internet is a global environment, using the Internet to collect and process personal information necessarily involves the transmission of information on an international basis. Therefore, by browsing the website and communicating electronically with us, you acknowledge and agree to iGen Capital Limited processing personal information in this way.
Subject access rights:
You have a right to a copy of and details of the personal information held about you. To obtain a copy of the personal information iGen Capital Limited holds about you, please write to us at Second Floor, 123 Aldersgate Street, London, EC1A 4JQ, United Kingdom. A charge of £10.00 will be made by iGen Capital Limited for providing this information.
Information on the Data Protection Act 1998 is also on the Information Commissioner’s website at www.ico.gov.uk.
Cookies are small files that collect anonymous information about how visitors use our site, which is then used to help improve the site. The information collected includes the number of site visitors, where visitors come to the site from and the pages they visited. For further information visit www.aboutcookies.org. Please note that by deleting our cookies or disabling future cookies you may not be able to access certain areas or features of our site.
by Maximilian De Maria
We are Master Distributors.
We don’t sell. We collaborate with allocators.
Our interests are aligned with our clients and investor network.
Closing. We will put you in front of investors.
On steroids. Due Diligence on your business, product and people.
We help you with your brand identity and design, outside-in.
You need distribution, that's why you are here. We aren't the only ones you have approached. By now you will have been through your phone book twice over and have a least one outsourced distributor "looking after" your fundraising needs. Don't worry, you aren't the only ones not receiving the capital you were promised. The industry has changed and we are the ones able to help you succeed in it.
– iGen Client
Our team members have allocated as principals across all major asset classes. We have seeded and incubated, and lifted individuals and teams out of their 'comfort zone'. We understand institutional requirements.
We help you balance your pitch between product positioning and business strategy. Investors demand transparency about your vision and we deliver.
Global HF $mln AuM (JPM Survey)
Cups of Coffee
You deserve to build your business. We are here to help you engage with the right investors, not with the many that others say you should. We focus on quality. Our investors demand that our due diligence on you meets their expectations. Therefore we make a significant investment in understanding your business, your product and your people. Our investment memoranda are unique in the industry. Guaranteed.
Coming from the buy-side, we have a deep understanding of what investable means and selecting the right funds to work with. We have a broad network of investors with capital to invest who share our views. Combining these two leads to an exceptionally high hit rate for the industry, allowing our clients to spend their time putting money to work.
March 16, 2018
March 1, 2018
February 10, 2017
We have access to first class investors due to long, established relationships. These are built on trust and on the understanding of our process. This mindset allows us to better qualify investments before approaching prospective investors. We do not work on quantity but on the basis of carefully selected opportunities.
The industry's best fund managers need more than just performance to succeed in this highly competitive market. Having the right distribution partner is essential to growing your assets with the right investors, allowing your investment team to focus on what they are best at.
Our engagement with asset managers begins with a full 360° due diligence program which is followed by a thorough feedback session. Our deep understanding of both the product and business are instrumental to our success in raising capital.
We meet a lot of very talented investment managers at iGen but can only distribute the few that have reached their full potential. When we find talent that could benefit from operational / managerial support, we direct them to our Venture Partner in Asset Management, CITE Investments.
– Client Board Member
Get in touch to find out more.
We'd be happy to talk.
Arrange a workshop with the team.
Let's get things started.
1 Fore Street, London
EC2Y 9DT United Kingdom
Please get in touch giving us an overview of your fund and a PDF presentation or fact sheet and we will be in contact shortly.
Your Name (required)
Your Email (required)
iGen Capital is an Appointed Representative of Finex LLP, a firm authorised and regulated by the Financial Conduct Authority.